144 related articles for article (PubMed ID: 18458643)
1. Rituximab-responsive cryoglobulinemic glomerulonephritis in a patient with autoimmune hepatitis.
Evans JT; Shepard MM; Oates JC; Self SE; Reuben A
J Clin Gastroenterol; 2008 Aug; 42(7):862-3. PubMed ID: 18458643
[No Abstract] [Full Text] [Related]
2. [Monoclonal antibodies to B-lymphocytes (rituximab) in the treatment of HCV-associated severe cryoglobulinemic glomerulonephritis].
Milovanova SIu; Lopatkina TN; Kozlovskaia LV; Krasnova TN
Ter Arkh; 2007; 79(6):69-72. PubMed ID: 17684972
[No Abstract] [Full Text] [Related]
3. [Treatment with rituximab in a patient with mononeuritis multiplex asocciated to hepatitis C infection with mixed cryoglobulinemia].
Ivorra J; Muñoz S; Román-Ivorra J; Beltrán E
Med Clin (Barc); 2009 Mar; 132(11):444-5. PubMed ID: 19268328
[No Abstract] [Full Text] [Related]
4. A patient presenting with isolated hematuria and renal dysfunction as rare manifestation of cryoglobulinemic glomerulonephritis in the course of autoimmune diseases including Sjögren's syndrome.
Yamanaka M; Fujigaki Y; Kono H; Nagura M; Arai S; Tamura Y; Ota T; Shibata S; Kondo F; Yamaguchi Y; Uchida S
CEN Case Rep; 2018 Nov; 7(2):211-216. PubMed ID: 29671215
[TBL] [Abstract][Full Text] [Related]
5. Anti-CD20 monoclonal antibody (rituximab) treatment for hepatitis C-negative therapy-resistant essential mixed cryoglobulinemia with renal and cardiac failure.
Ghijsels E; Lerut E; Vanrenterghem Y; Kuypers D
Am J Kidney Dis; 2004 May; 43(5):e34-8. PubMed ID: 15112197
[TBL] [Abstract][Full Text] [Related]
6. [Hepatitis associated cryoglobulinemia].
Pischke S; Cornberg M; Manns MP
Internist (Berl); 2008 Mar; 49(3):297-304. PubMed ID: 18327517
[TBL] [Abstract][Full Text] [Related]
7. Rituximab as a therapeutic tool in severe mixed cryoglobulinemia.
Roccatello D; Baldovino S; Rossi D; Giachino O; Mansouri M; Naretto C; Di Simone D; Francica S; Cavallo R; Alpa M; Napoli F; Sena LM
Clin Rev Allergy Immunol; 2008 Feb; 34(1):111-7. PubMed ID: 18270864
[TBL] [Abstract][Full Text] [Related]
8. Cryoglobulin-induced cardiomyopathy.
Karras A; Potier L; Reboux AH; Coldea N; Perdrix L; Jacquot C; Mousseaux E
J Am Coll Cardiol; 2010 Feb; 55(7):e13. PubMed ID: 20170783
[No Abstract] [Full Text] [Related]
9. Hepatitis C virus-related cryoglobulinemic vasculitis: emerging trends in therapy.
St Clair EW
Arthritis Rheum; 2012 Mar; 64(3):604-8. PubMed ID: 22147537
[No Abstract] [Full Text] [Related]
10. Disappearance of bone marrow B cell clonal expansion in patients with type II hepatitis C virus-related cryoglobulinemic glomerulonephritis after clinical efficient rituximab therapy.
Quartuccio L; Salvin S; Fabris M; Sacco S; De Vita S
Ann Rheum Dis; 2008 Oct; 67(10):1494-5. PubMed ID: 18791058
[No Abstract] [Full Text] [Related]
11. Rituximab treatment for a patient with type I cryoglobulinemic glomerulonephritis.
Pandrangi S; Singh A; Wheeler DE; Rossi NF
Nat Clin Pract Nephrol; 2008 Jul; 4(7):393-7. PubMed ID: 18493239
[TBL] [Abstract][Full Text] [Related]
12. Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection.
Benstead TJ; Chalk CH; Parks NE
Cochrane Database Syst Rev; 2014 Dec; (12):CD010404. PubMed ID: 25525951
[TBL] [Abstract][Full Text] [Related]
13. Treatment of cryoglobulinemia associated peripheral neuropathy with rituximab.
Cai FZ; Ahern M; Smith M
J Rheumatol; 2006 Jun; 33(6):1197-8. PubMed ID: 16755669
[TBL] [Abstract][Full Text] [Related]
14. Rapidly fatal Acanthamoeba encephalitis and treatment of cryoglobulinemia.
Meersseman W; Lagrou K; Sciot R; de Jonckheere J; Haberler C; Walochnik J; Peetermans WE; van Wijngaerden E
Emerg Infect Dis; 2007 Mar; 13(3):469-71. PubMed ID: 17552103
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and risk of rituximab in type II mixed cryoglobulinemia: a significant case report.
Massari M; Catania A; Magnani G
Dig Liver Dis; 2007 Sep; 39 Suppl 1():S134-5. PubMed ID: 17936216
[No Abstract] [Full Text] [Related]
16. A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis.
De Vita S; Quartuccio L; Isola M; Mazzaro C; Scaini P; Lenzi M; Campanini M; Naclerio C; Tavoni A; Pietrogrande M; Ferri C; Mascia MT; Masolini P; Zabotti A; Maset M; Roccatello D; Zignego AL; Pioltelli P; Gabrielli A; Filippini D; Perrella O; Migliaresi S; Galli M; Bombardieri S; Monti G
Arthritis Rheum; 2012 Mar; 64(3):843-53. PubMed ID: 22147661
[TBL] [Abstract][Full Text] [Related]
17. Life-threatening infections following rituximab therapy in renal transplant patients with mixed cryoglobulinemia.
Basse G; Ribes D; Kamar N; Esposito L; Rostaing L
Clin Nephrol; 2006 Nov; 66(5):395-6. PubMed ID: 17140171
[No Abstract] [Full Text] [Related]
18. Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry.
Terrier B; Launay D; Kaplanski G; Hot A; Larroche C; Cathébras P; Combe B; de Jaureguiberry JP; Meyer O; Schaeverbeke T; Somogyi A; Tricot L; Zénone T; Ravaud P; Gottenberg JE; Mariette X; Cacoub P
Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1787-95. PubMed ID: 20740617
[TBL] [Abstract][Full Text] [Related]
19. Acute renal failure secondary to severe type I cryoglobulinemia following rituximab therapy for Waldenström's macroglobulinemia.
Shaikh A; Habermann TM; Fidler ME; Kumar S; Leung N
Clin Exp Nephrol; 2008 Aug; 12(4):292-295. PubMed ID: 18288560
[TBL] [Abstract][Full Text] [Related]
20. Rituximab for the treatment of glomerulonephritis in hepatitis C associated cryoglobulinaemia.
Korte MR; van Heerde MJ; de Man RA; Betjes MH
Neth J Med; 2008 Jan; 66(1):27-30. PubMed ID: 18219065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
